Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients [Phase 1]
This clinical trial update reports a Phase 1 study of TG01 in combination with erlotinib in non-small cell lung cancer. The study status is …
-
CLINICAL_TRIALS trial_result · 2010-03-12Clinical Trial Update: A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers [Phase 1]
Pfizer completed a Phase 1 radiolabeled mass-balance study of [14C]PF-00299804 in healthy male volunteers, assessing pharmacokinetics and ex…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating the safety and preliminary efficacy of an oral taxane in combination with pemetrexed (Alimta) in patients with re…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating BMS-275183 in patients with pre-treated non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) [Phase 2]
Phase 2 study of Bristol-Myers Squibb's BMS-275183 in pretreated locally advanced or metastatic non-small cell lung cancer has been terminat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-02-22Clinical Trial Update: Study of XL999 in Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial of XL999 in non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-19Clinical Trial Update: Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer [Phase 1]
Phase 1 safety study of XL999 in adults with non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
This clinical trial update notes that a Phase 2 study of Pulmonart (docetaxel) for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer [Phase 2]
This Clinical Trials update reports the completion of a Phase 2 study evaluating radiofrequency ablation during surgery for non-small cell l…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy [Phase 3]
Phase 3 clinical trial update evaluating the combination of pemetrexed (ALIMTA) and gefitinib (IRESSA) in never-smoker patients with adenoca…
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating induction chemotherapy followed by intensity-modulated radiation therapy guided by combined CT a…
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated the combination of docetaxel and thalidomide as second-line therapy for stage III or IV non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of pazopanib monotherapy in advanced non-small cell lung cancer was terminated, with results posted in January 2010.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib [Phase 1, Phase 2]
Clinical trial update for advanced non-small cell lung cancer evaluating pemetrexed and carboplatin with or without sorafenib. The study is …
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 multicenter trial evaluating a docetaxel/gemcitabine/bevacizumab regimen followed by bevacizumab alone in locally advanced or metast…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating all-trans retinoic acid in combination with paclitaxel and cisplatin as first-line therapy for advanced non-small c…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating pemetrexed in combination with platinum chemotherapy for advanced non-small-cell lung cancer; results were posted i…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer [Phase 1]
This document reports the completion of a Phase 1 study evaluating concurrent radiotherapy with weekly topotecan as primary treatment for pa…
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of GW572016 (lapatinib) in advanced or metastatic non-small cell lung cancer; the trial was terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2010-01-05Clinical Trial Update: Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer [Phase 2]
This document reports an update on a Phase 2 trial of assisted-VATS sleeve lobectomy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2010-01-01Clinical Trial Update: Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker [Phase 3]
A Phase 3 clinical trial is described evaluating All-trans Retinoic Acid with paclitaxel and cisplatin as first-line therapy for advanced no…
-
CLINICAL_TRIALS trial_result · 2009-12-25Clinical Trial Update: Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating gemcitabine alone or with docetaxel after cisplatin, etoposide, and radiation in patients with non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial evaluating UFUR (tegafur/uracil) in combination with Iressa (gefitinib) for non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients [Phase 2]
Phase 2 safety study evaluating docetaxel/cisplatin induction therapy followed by concurrent chemoradiotherapy, or concurrent chemoradiother…
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV [Phase 2]
The document reports the completion of a Phase 2 trial evaluating erlotinib as first-line therapy for non-small cell lung cancer in stage II…